Aspirin linked to Age-Related Macular Degeneration (AMD) vision loss
An Australian population-based study conducted during a 15-year period found that regular aspirin users suffered AMD vision loss at a rate of 9.3% compared to a non-aspirin users rate of 3.7% as reported in the January 21, 2012 JAMA Internal Medicine on line.
Of 2389 baseline participants with follow-up data available, 257 individuals (10.8%) were regular aspirin users and 63 of these (24.5%) developed neovascular AMD. Persons who were regular aspirin users were more likely to have incident neovascular AMD: the 15-year cumulative incidence was 9.3% in users and 3.7% in nonusers.
The study concluded that;
Regular aspirin use is associated with increased risk of incident neovascular AMD, independent of a history of cardiovascular disease and smoking.
The full research article is available online at: